טיגציל

国家: 以色列

语言: 希伯来文

来源: Ministry of Health

有效成分:

TIGECYCLINE

可用日期:

PFIZER PFE PHARMACEUTICALS ISRAEL LTD

ATC代码:

J01AA12

药物剂型:

אבקה להכנת תמיסה לאינפוזיה

组成:

TIGECYCLINE 50 MG/DOSE

给药途径:

תוך-ורידי

处方类型:

מרשם נדרש

厂商:

PFIZER INC, USA

治疗组:

TIGECYCLINE

治疗领域:

TIGECYCLINE

疗效迹象:

TYGACIL is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below for patients 18 years of age and older:Complicated Skin and Skin Structure Infections:Complicated skin and skin structure infections caused by Escherichia coli, Enterococcus faecalis (vancomycin-susceptible isolates ), Staphylococcus aureus (methicillin-susceptible and -resistant isolates), Streptococcus agalactiae, Streptococcus anginosus grp. (includes S. anginosus, S. intermedius, and S. constellatus), Streptococcus pyogenes, Enterobacter cloacae, Klebsiella pneumoniae, and Bacteroides fragilis .Complicated Intra-abdominal Infections:Complicated intra-abdominal infections caused by Citrobacter freundii, Enterobacter cloacae, Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae, Enterococcus faecalis (vancomycin-susceptible isolates), Staphylococcus aureus (methicillin-susceptible and -resistant isolates), Streptococcus anginosus grp. (includes S. anginosu

授权日期:

2022-02-28